InDevR, Inc. | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
InDevR, Inc.

BRIEF

published on 06/25/2024 at 17:05, 4 months 25 days ago

InDevR Launches 5’CapQ for Rapid Quality Testing of mRNA-Based Vaccines

InDevR Vaccine MRNA Quality Testing 5'CapQ
PRESS RELEASE

published on 06/25/2024 at 17:00, 4 months 25 days ago

InDevR Launches 5’CapQ for Rapid Critical Quality Attribute Determination of mRNA-Based Vaccines
InDevR Inc. launches 5'Cap Q kit for fast determination of mRNA 5' capping efficiency on their VaxArray Platform, providing results in less than two hours

VaxArray Platform InDevR Inc. MRNA 5'Cap Q Kit Vaccine Production
BRIEF

published on 06/05/2024 at 17:05, 5 months 15 days ago

InDevR and Sino Biological Partner to Enhance Analytical Solutions for mRNA Vaccines and Cell & Gene Therapy

InDevR MRNA Vaccine Sino Biological Analytical Solutions Cell & Gene Therapy
PRESS RELEASE

published on 06/05/2024 at 17:00, 5 months 15 days ago

InDevR and Sino Biological Team Up to Deliver Multiplexed Analytical Solutions for mRNA Vaccine and Cell & Gene Therapy
InDevR, Inc. and Sino Biological partner to develop multiplexed assays for vaccine, mRNA therapies, and cell and gene therapy. The partnership aims to accelerate analytical tool deployment in the biopharmaceutical industry

Partnership Biopharmaceutical Industry InDevR Inc. Sino Biological Multiplexed Assays
BRIEF

published on 05/22/2024 at 21:35, 5 months 29 days ago

InDevR Unveils OmniFlu HA Kit to Enhance Influenza Vaccine Development

InDevR Influenza Vaccine OmniFlu HA Hemagglutinin VaxArray
PRESS RELEASE

published on 05/22/2024 at 21:30, 5 months 29 days ago

InDevR Introduces Latest Solution for Influenza Vaccine Manufacturers, OmniFlu HA, to Simplify Vaccine Testing and Speed Time to Market
InDevR launches OmniFlu HA, a validated kit for multiplexed seasonal HA detection and quantification, assisting vaccine developers. Streamlines vaccine characterization with microarray technology

InDevR OmniFlu HA Seasonal Influenza Vaccine Manufacturers Multiplexed Assay
BRIEF

published on 03/05/2024 at 19:35, 8 months 15 days ago

InDevR Launches Expert Services to Address Vaccine Development Challenges

InDevR Vaccine Development Expert Services VaxArray Platform Biotherapeutics
PRESS RELEASE

published on 03/05/2024 at 19:30, 8 months 15 days ago

InDevR Launches Expert Services to Address Vaccine Development Challenges
InDevR Inc. launches Expert Services, offering tailored workflow solutions to accelerate vaccine analysis and validation. A comprehensive solution for vaccine manufacturers

Vaccine Development Expert Services InDevR Inc. Vaccine Analysis Workflow Solutions

Accesswire

Published on 11/21/2024 at 10:03, 41 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 44 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 44 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 9 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 19 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 14 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 39 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 42 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 44 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 44 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 46 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 24 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 59 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 59 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE